TIDMSWC

RNS Number : 9642M

Summerway Capital PLC

24 September 2021

24 September 2021

Summerway Capital Plc

("Summerway" or the "Company")

Posting of Circular and Notice of General Meeting

Further to the announcement on 21 September 2021 in relation to the Company's proposed amendment to its Investing Policy, the Board of Directors of Summerway Capital Plc (AIM: SWC) announce that the Company is today posting a circular to Shareholders.

The Circular contains a notice convening a General Meeting of the Company, at which the resolution in connection with the new investing policy will be put to shareholders. The meeting will be held at 12.00 p.m. on 20 October 2021 at the offices of Canaccord Genuity Limited at 88 Wood Street, London, EC2V 7QR.

As the UK Government's restrictions on social distancing and restrictions on attendance at public gatherings have been lifted, the Board looks forward to welcoming Shareholders in person at the General Meeting. However, given the evolving nature of the situation and the possibility for circumstances to change before the date of the General Meeting such that larger gatherings indoors are no longer permissible and the Board is forced to revise its position and run the General Meeting as a closed meeting, Shareholders are encouraged to appoint the Chair of the General Meeting as their proxy to ensure that their vote is able to be cast in accordance with their wishes.

The Board will keep the situation under review and may need to make further changes to the arrangements relating to the General Meeting, including how it is conducted. Shareholders should therefore continue to monitor the Company's website and announcements via a regulatory information service for any updates in relation to the General Meeting arrangements that may need to be provided.

The Company has received irrevocable undertakings from certain shareholders and Directors to vote in favour of the Resolution to be put to shareholders at the forthcoming General Meeting, in respect of their direct holdings, representing in aggregate 76.4% of the Company's existing issued share capital.

The Circular and the Notice of General Meeting will also be available for viewing on the Company's website at www.summerwaycapital.co.uk.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

Enquiries:

Summerway Capital Plc

   Tony Morris        020 7440 7520 
   Canaccord Genuity Limited         (Nominated Adviser and Broker) 
   Andrew Potts    020 7523 8000 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOGBUGDCIUDDGBS

(END) Dow Jones Newswires

September 24, 2021 12:06 ET (16:06 GMT)

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Celadon Pharmaceuticals Charts.